Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia

Hypertension

Volumn 27, Issue 6, 1996, Pages 1205-1209

  Nakata, Yukiko ^a   Katsuya, Tomohiro ^a   Rakugi, Hiromi ^a   Takami, Seiju ^a   Ohishi, Mitsuru ^a   Kamino, Kouzin ^a   Higaki, Jitsuo ^a   Tabuchi, Yoshikatsu ^b   Kumahara, Yuichi ^b   Miki, Tetsuro ^a   Ogihara, Toshio ^a,c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Japan Res Found for Chron Dis   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

angiotensin converting enzyme; apolipoprotein E; genetics; myocardial ischemia; polymorphism

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 9344257267     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.6.1205     Document Type: Article

References (35)

1. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
2. Zhao Y. Higashimori K, Higaki J, Kamitani A, Ohishi M, Katsuya T, Miki T, Mikami H, Minamino T, Ogihara T. Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res. 1994;17:55-57.
3. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 1993;71:160-165.
4. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H, Ogihara T. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 1995;25:950-953.
5. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1600-1603.
6. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
7. Schunkert H, Hense HW, Holmer SR, Slender M, Perz S, Keil U, Lorell BH, Riegger GA. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
8. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994;90:2622-2628.
9. Ohishi M, Rakugi H, Ogihara T. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;331:1097-1098.
10. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
11. Ferrieres J, Sing CF, Roy M, Davignon J, Lussier CS. Apolipoprotein E polymorphism and heterozygous familial hypercholes-terolemia: sex-specific effects. Arterioscler Thromb. 1994;14: 1553-1560.
12. Akhtar M, Das BK, Chatterji JC. Master double two-step exercise (DMT) with telemetry and submaximal treadmill exercise: a comparative study. Indian Heart J. 1980;32:130-136.
13. Master AM. Exercise testing for evaluation of cardiac performance. Am J Cardiol. 1972;30:718-721.
14. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, White R, Lalouel JM. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics. 1988;3:373-379.
15. Tiret L. Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51: 197-205.
16. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JB, Cambien F. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: The ECTIM Study. Arterioscler Thromb. 1994;14: 1412-1419.
17. Tiret L, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb. 1994;14:1617-1624.
18. Nieminen MS, Mattila KJ, Setala KA, Kuusi T, Kontula K, Makelin RK, Ehnholm C, Jauhiainen M, Valle M, Taskinen MR. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb. 1992;12:58-69.
19. Wang XL, McCredie RM, Wilcken DEL. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vase Biol. 1995;15: 1030-1034.
20. Katzel LI, Fleg JL, Paidi M, Ragoobarsingh N, Goldberg AP. ApoE4 polymorphism increases the risk for exercise-induced silent myocardial ischemia in older men. Arterioscler Thromb. 1993;13: 1495-1500.
21. Cohn PF. Silent myocardial ischemia: dimensions of the problem in patients with and without angina. Am J Med. 1986;80:3-8.
22. Gordon DJ, Ekelund LG, Karon JM, Probstfield JL, Rubenstein C, Sheffield LT, Weissfeld L. Predictive value of the exercise tolerance test for mortality in North American men: the Lipid Research Clinics Mortality Follow-up Study. Circulation. 1986;74:252-261.
23. Giagnoni E, Secchi MB, Wu SC, Morabito A, Oltrona L, Mancarella S, Volpin N, Fossa L, Bettazzi L, Arangio G. Prognostic value of exercise EKG testing in asymptomatic normotensive subjects: a prospective matched study. N Engl J Med. 1983;309:1085-1089.
24. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
25. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb. 1991;11: 1237-1244.
26. Avila EM, Holdsworth G, Sasaki N, Jackson RL, Harmony JA. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J Biol Chem. 1982;257:5900-5909.
27. Pepe MG, Curtiss LK. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. J Immunol. 1986;136:3716-3723.
28. Vogel T, Guo NH, Guy R, Drezlich N, Krutzsch HC, Blake DA, Panel A, Roberts DD. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem. 1994;54: 299-308.
29. Saxena U, Ferguson E, Bisgaier CL. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix. J Biol Chem. 1943;268:14812-14819.
30. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995;91:2120-2124.
31. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
32. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Amouyel P. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993;341:991-992.
33. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994;90:2199-2202.
34. Ohishi M, Rakugi H, Higaki J, Miki T, Ogihara T. Angiotensin-converting-enzyme genotype and ischemic heart disease. N Engl J Med. 1995;333:458-460.
35. Tiret L, Bonnardeaux A, Poirier DO, Ricard S, Vidal PM, Evans A, Arveiler D, Luc G, Kee F, Ducimetière P. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994; 344:910-913.